An 8 Weeks Open Label National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Amlodipine/valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2011 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 24 Nov 2010 New trial record